Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 1
1963 1
1967 1
1974 1
1981 1
1984 2
1985 2
1986 1
1987 3
1990 5
1991 4
1992 6
1993 3
1994 6
1995 5
1996 3
1997 7
1998 5
1999 6
2000 8
2001 11
2002 14
2003 22
2004 7
2005 20
2006 17
2007 18
2008 15
2009 24
2010 21
2011 32
2012 25
2013 29
2014 22
2015 30
2016 38
2017 43
2018 36
2019 38
2020 42
2021 48
2022 47
2023 26
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

593 results

Results by year

Filters applied: . Clear all
Page 1
Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER.
Monés J, Srivastava SK, Jaffe GJ, Tadayoni R, Albini TA, Kaiser PK, Holz FG, Korobelnik JF, Kim IK, Pruente C, Murray TG, Heier JS. Monés J, et al. Ophthalmology. 2021 Jul;128(7):1050-1059. doi: 10.1016/j.ophtha.2020.11.011. Epub 2020 Nov 15. Ophthalmology. 2021. PMID: 33207259 Free article. Clinical Trial.
RESULTS: Fifty brolucizumab-treated eyes were considered to have definite/probable drug-related events within the spectrum of IOI, retinal vasculitis, and/or vascular occlusion. On the basis of these cases, incidence of definite/probable IOI was 4.6% (IOI + vasculit …
RESULTS: Fifty brolucizumab-treated eyes were considered to have definite/probable drug-related events within the spectrum of IOI, retina …
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis.
Agrawal R, Testi I, Bodaghi B, Barisani-Asenbauer T, McCluskey P, Agarwal A, Kempen JH, Gupta A, Smith JR, de Smet MD, Yuen YS, Mahajan S, Kon OM, Nguyen QD, Pavesio C, Gupta V; Collaborative Ocular Tuberculosis Study Consensus Group. Agrawal R, et al. Ophthalmology. 2021 Feb;128(2):277-287. doi: 10.1016/j.ophtha.2020.06.052. Epub 2020 Jun 27. Ophthalmology. 2021. PMID: 32603726
TOPIC: The Collaborative Ocular Tuberculosis Study (COTS), supported by the International Ocular Inflammation Society, International Uveitis Study Group, and Foster Ocular Immunological Society, set up an international, expert-led consensus project to develop evidence- and experi …
TOPIC: The Collaborative Ocular Tuberculosis Study (COTS), supported by the International Ocular Inflammation Society, International Uveitis …
Eales Disease.
Khan MN, Raza SS, Qadir S, Rehman H, Hussain AK, Nadeem MD, Ullah F. Khan MN, et al. J Ayub Med Coll Abbottabad. 2016 Oct-Dec;28(4):816-817. J Ayub Med Coll Abbottabad. 2016. PMID: 28586583 Free article.
Various systemic diseases associated with peripheral retinal revascularization and Retinal vasculitis could imitate the proliferative and inflammatory phases of Eales' disease, respectively. We present a case of a 30 years old female patient with Eales disease and d …
Various systemic diseases associated with peripheral retinal revascularization and Retinal vasculitis could imitate the prolif …
Eye and Behçet's disease.
Ksiaa I, Abroug N, Kechida M, Zina S, Jelliti B, Khochtali S, Attia S, Khairallah M. Ksiaa I, et al. J Fr Ophtalmol. 2019 Apr;42(4):e133-e146. doi: 10.1016/j.jfo.2019.02.002. Epub 2019 Mar 5. J Fr Ophtalmol. 2019. PMID: 30850197 Review.
It typically presents in the form of relapsing-remitting panuveitis with retinal vasculitis that may result in severe visual loss. Management of Behcet's uveitis relies on corticosteroid therapy, conventional immunosuppressive drugs and biological agents and require …
It typically presents in the form of relapsing-remitting panuveitis with retinal vasculitis that may result in severe visual l …
Retinal vasculitis.
Walton RC, Ashmore ED. Walton RC, et al. Curr Opin Ophthalmol. 2003 Dec;14(6):413-9. doi: 10.1097/00055735-200312000-00015. Curr Opin Ophthalmol. 2003. PMID: 14615648 Review.
Retinal vasculitis represents a group of diseases characterized by inflammation affecting the retinal vasculature. ...The management of infectious causes of retinal vasculitis consists of antimicrobial therapy while noninfectious retinal vasc …
Retinal vasculitis represents a group of diseases characterized by inflammation affecting the retinal vasculature. ...The mana …
Complications of intravitreal injections: 2022.
Patel D, Patel SN, Chaudhary V, Garg SJ. Patel D, et al. Curr Opin Ophthalmol. 2022 May 1;33(3):137-146. doi: 10.1097/ICU.0000000000000850. Epub 2022 Mar 9. Curr Opin Ophthalmol. 2022. PMID: 35266893 Review.
RECENT FINDINGS: Intravitreal vancomycin can cause hemorrhagic occlusive retinal vasculitis resulting in severe vision loss. Intravitreal brolucizumab is associated with intraocular inflammation and retinal vasculitis resulting in significant vision lo …
RECENT FINDINGS: Intravitreal vancomycin can cause hemorrhagic occlusive retinal vasculitis resulting in severe vision loss. I …
Multimodal Imaging in Retinal Vasculitis.
Agarwal A, Afridi R, Agrawal R, Do DV, Gupta V, Nguyen QD. Agarwal A, et al. Ocul Immunol Inflamm. 2017 Jun;25(3):424-433. doi: 10.1080/09273948.2017.1319494. Ocul Immunol Inflamm. 2017. PMID: 28696172 Review.
Retinal vasculitis presents with inflammation involving the retinal vasculature as an isolated disease or in combination with other ocular or systemic conditions. ...Often, retinal vasculitis and its complications lead to diagnostic challenges in ident …
Retinal vasculitis presents with inflammation involving the retinal vasculature as an isolated disease or in combination with …
Multimodal Imaging in Ocular Sarcoidosis.
Mahendradas P, Maruyama K, Mizuuchi K, Kawali A, Kitaichi N. Mahendradas P, et al. Ocul Immunol Inflamm. 2020 Nov 16;28(8):1205-1211. doi: 10.1080/09273948.2020.1751210. Epub 2020 May 12. Ocul Immunol Inflamm. 2020. PMID: 32396030 Review.
Aim: Ocular sarcoidosis presents a diagnostic challenge because of its varied clinical presentations. It is important to distinguish sarcoidosis from other uveitis diseases. Multimodal imaging provides useful data to be introduced into clinical practice. Methods: Th …
Aim: Ocular sarcoidosis presents a diagnostic challenge because of its varied clinical presentations. It is important to distinguish …
Post-streptococcal vasculitis.
Reddy UP, Albini TA, Banta JT, Davis JL. Reddy UP, et al. Ocul Immunol Inflamm. 2008 Jan-Feb;16(1):35-6. doi: 10.1080/09273940701799163. Ocul Immunol Inflamm. 2008. PMID: 18379940
PURPOSE: To report a case of post-streptococcal retinal vasculitis. DESIGN: Review of a case. METHODS: Review of patient chart and fluorescein angiography. ...CONCLUSIONS: Although CNS vasculitis is well recognized as a post-streptococcal syndrome, this case illustr …
PURPOSE: To report a case of post-streptococcal retinal vasculitis. DESIGN: Review of a case. METHODS: Review of patient chart …
Retinal vasculitis.
Levy-Clarke GA, Nussenblatt R. Levy-Clarke GA, et al. Int Ophthalmol Clin. 2005 Spring;45(2):99-113. doi: 10.1097/01.iio.0000155905.95303.1d. Int Ophthalmol Clin. 2005. PMID: 15791161 Review. No abstract available.
593 results